» Articles » PMID: 28396132

Clostridium Difficile Infection

Overview
Journal Med Clin (Barc)
Specialty General Medicine
Date 2017 Apr 12
PMID 28396132
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Clostridium difficile infection (CDI) is the main cause of nosocomial diarrhea in industrialized countries and the source of a growing number of cases of diarrhea in the community. The outbreak of the hypervirulent strain belonging to ribotype 027 has increased the incidence and severity of CDI in some countries. Although CDI usually courses as a mild diarrhea it can lead to severe forms such as toxic megacolon or septic shock. One of every 2 episodes of CDI is not diagnosed in Spanish hospitals due to a lack of clinical suspicion or the use of insensitive diagnostic methods. The diagnostic techniques of choice are algorithms based on the detection of glutamate dehydrogenase and molecular detection of the genes of the toxins with or without the direct detection of the toxins. The recommended treatment for CDI depends on the type of infection and the characteristics of the patient.

Citing Articles

Risk factors for Clostridioides difficile infection among patients diagnosed with inflammatory intestinal and rheumatological diseases in the biologic era.

Martinez-Lozano H, Saralegui-Gonzalez P, Reigadas E, Fueyo-Pelaez P, Garcia-Garcia A, Miranda-Bautista J BMC Gastroenterol. 2025; 25(1):70.

PMID: 39923011 PMC: 11806733. DOI: 10.1186/s12876-025-03650-3.


Economic burden of recurrent Clostridioides difficile infection in adults admitted to Spanish hospitals. A multicentre retrospective observational study.

Bouza E, Cobo J, Rodriguez-Hernandez M, Salavert M, Horcajada J, Iribarren J Rev Esp Quimioter. 2021; 34(2):126-135.

PMID: 33618513 PMC: 8019457. DOI: 10.37201/req/135.2020.


Doctor, my patient has CDI and should continue to receive antibiotics. The (unresolved) risk of recurrent CDI.

Castro I, Tasias M, Calabuig E, Salavert M Rev Esp Quimioter. 2019; 32 Suppl 2:47-54.

PMID: 31475811 PMC: 6755365.


Update in Infectious Diseases 2019.

Candel F, Rico C, Diaz de la Torre I, Laguna B, Martinez-Jordan J, Medrano S Rev Esp Quimioter. 2019; 32 Suppl 2:1-9.

PMID: 31475801 PMC: 6755363.


Antibacterial Activity of Against .

Yang J, Yang H Front Cell Infect Microbiol. 2019; 9:288.

PMID: 31440478 PMC: 6693512. DOI: 10.3389/fcimb.2019.00288.